Bahtiyar Toz, MD

Bahtiyar Toz, MD, Icahn School of Medicine, Mount Sinai

Icahn School of Medicine, Mount Sinai

Articles by Bahtiyar Toz, MD

Obinutuzumab Shows Durable Kidney Protection and High Remission Rates in Lupus Nephritis, with Bahtiyar Toz, MD

Obinutuzumab Shows Durable Kidney Protection and High Remission Rates in Lupus Nephritis, with Bahtiyar Toz, MD

ByBahtiyar Toz, MD

October 28th 2025

Obinutuzumab was approved earlier in October for LN under the name Gazyva.

Latest Updated Articles

Obinutuzumab Shows Durable Kidney Protection and High Remission Rates in Lupus Nephritis, with Bahtiyar Toz, MD
Published: October 28th 2025 | Updated: